Annals of Surgery Open · 2024 · 15 citations · 22 references
MedicinePerioperative MedicineSurgeryAssistive TechnologyPerioperative Outcomes ResearchSurgical OncologyAugmented RealityAugmented Reality In MedicinePancreatic CancerPancreatic SurgeryWearable Augmented Reality InterfacesAugmented Reality SurgeryHospital Stay DurationMatched Control GroupNeoadjuvant ChemoradiotherapyPancreatic Cancer ResectionPancreatic Surgery Complications ManagementPostoperative Care After Pancreatic SurgeryWearable Augmented Reality
Objective: The present study aimed to evaluate the safety of the first wearable augmented reality assistance system (ARAS) specifically designed for pancreatic surgery and its impact on perioperative outcomes. Background: Pancreatic surgery remains highly complex and is associated with a high rate of perioperative complications. ARAS, as an intraoperative assistance system, has the potential to reduce these complications. Methods: This prospective, single-center study included 20 patients who underwent pancreatic surgery using ARAS. These patients were matched in a 1:3 ratio with 60 patients from our retrospective data who underwent standard pancreatic resection. Matching variables were selected based on factors associated with poor intraoperative outcomes. Results: A higher proportion of patients in the ARAS group were diagnosed with borderline resectable pancreatic cancer and received neoadjuvant chemotherapy (20.0% vs 6.7%, P = 0.085). Additionally, more patients in the ARAS group required arterial resection compared with the control group (15.0% vs 0.0%, P = 0.002). Nevertheless, the ARAS group had a significantly shorter operative time (246 vs 299 minutes, P = 0.004) and required significantly fewer intraoperative blood transfusions (0.0 ± 0.0 vs 0.5 ± 1.4 units, P = 0.014). None of the patients in the ARAS group had positive resection margins (0.0% vs 20.0%, P = 0.045). Furthermore, patients in the ARAS group experienced a significantly shorter hospital stay (13.8 ± 6.6 vs 17.9 ± 8.2 days, P = 0.046). Conclusions: ARAS is a safe and effective assistance system for pancreatic surgery, offering superior perioperative outcomes compared with standard procedures.
22
The Clavien-Dindo Classification of Surgical Complications
Pierre A. Clavien, Jeffrey Barkun, Michelle Oliveira et al. · Annals of Surgery · 2009 · 11.3K citations
Locally Advanced Pancreatic Cancer
Thilo Hackert, Milena Sachsenmaier, Ulf Hinz et al. · Annals of Surgery · 2016 · 534 citations
Oliver Strobel, Thomas Hank, Ulf Hinz et al. · Annals of Surgery · 2016 · 338 citations